Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001013762-23-000102
Filing Date
2023-10-02
Accepted
2023-09-29 21:27:29
Documents
5
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a0923_adialpharma.htm DEF 14A 1132726
2 GRAPHIC tadial_logo.jpg GRAPHIC 114536
3 GRAPHIC tadial_logo1.jpg GRAPHIC 114541
4 GRAPHIC tproxy_001.jpg GRAPHIC 1272698
5 GRAPHIC tproxy_002.jpg GRAPHIC 899137
  Complete submission text file 0001013762-23-000102.txt   4441831
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38323 | Film No.: 231297415
SIC: 2834 Pharmaceutical Preparations